AADR vs. CNCR ETF Comparison

Comparison of WCM BNY Mellon Focused Growth ADR ETF (AADR) to Loncar Cancer Immunotherapy ETF (CNCR)
AADR

WCM BNY Mellon Focused Growth ADR ETF

AADR Description

The investment seeks long-term capital appreciation above international benchmarks such as the BNY Mellon Classic ADR Index, the fund's primary benchmark, and the MSCI EAFE Index, the fund's secondary benchmark. The sub-advisor seeks to achieve the fund's investment objective by selecting primarily a portfolio of U.S.-traded securities of non-U.S. organizations, most often American Depositary Receipts ("ADRs"), included in the BNY Mellon Classic ADR Index. The fund's investment focus follows the Sub-Advisor's core philosophy of investing in industry-leading non-U.S. organizations led by visionary management teams with sound business strategies.

Grade (RS Rating)

Last Trade

$62.20

Average Daily Volume

1,098

Number of Holdings *

29

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$16.57

Average Daily Volume

39,291

Number of Holdings *

73

* may have additional holdings in another (foreign) market
Performance
Period AADR CNCR
30 Days 6.89% -1.14%
60 Days 10.84% 17.58%
90 Days 10.98% 18.94%
12 Months 33.30% 37.70%
0 Overlapping Holdings
Symbol Grade Weight in AADR Weight in CNCR Overlap
AADR Overweight 29 Positions Relative to CNCR
Symbol Grade Weight
NVO C 6.66%
YPF A 4.21%
BBVA A 3.42%
MUFG C 3.42%
ABBV C 3.37%
ERJ A 3.08%
CX B 3.03%
BMA B 2.97%
RELX B 2.9%
ASX B 2.85%
FMX D 2.74%
SAP A 2.73%
GGAL B 2.63%
KOF C 2.61%
NMR B 2.59%
PAM D 2.52%
HMY C 2.4%
TNP B 2.39%
MELI D 2.35%
LOGI C 2.32%
ING A 2.24%
NXPI C 2.23%
SMFG B 2.23%
PBR F 2.2%
VIPS C 2.03%
AVDL B 1.99%
VIV D 1.8%
E C 1.72%
ELP D 0.9%
AADR Underweight 73 Positions Relative to CNCR
Symbol Grade Weight
JANX C -3.67%
YMAB C -3.09%
MRSN D -3.08%
FATE C -3.07%
MGNX D -3.0%
IOVA C -2.65%
RVMD C -2.37%
MOR A -2.04%
AUTL C -1.98%
ACLX C -1.98%
KURA C -1.96%
KYMR C -1.95%
SWTX C -1.78%
MRUS C -1.75%
SMMT D -1.73%
ARVN D -1.62%
BPMC C -1.62%
NUVB C -1.57%
NUVL D -1.53%
INBX D -1.52%
CGEM C -1.49%
IDYA D -1.42%
PRLD C -1.38%
GERN C -1.37%
NRIX C -1.34%
IGMS D -1.26%
SNDX C -1.2%
GLUE C -1.15%
BCYC C -1.13%
RXRX D -1.13%
TSVT D -1.12%
LYEL F -1.1%
ACET F -1.09%
NGM D -1.08%
IMCR D -1.07%
KPTI D -1.07%
HCM C -1.07%
REGN B -1.07%
DCPH D -1.05%
MRK C -1.05%
TYRA D -1.03%
BMEA F -1.02%
ELVN D -1.02%
ALLO D -1.02%
EXEL B -1.0%
XNCR C -1.0%
DAWN C -0.98%
PGEN D -0.93%
FHTX C -0.92%
IMTX D -0.85%
ITOS D -0.84%
AURA D -0.83%
CRBU F -0.82%
STRO F -0.81%
LEGN D -0.8%
BMY D -0.79%
RLAY F -0.78%
VOR F -0.77%
SDGR F -0.76%
ERAS D -0.76%
RCUS D -0.76%
IPHA F -0.75%
BNTX F -0.74%
GMAB D -0.71%
ACRV D -0.55%
DNA F -0.54%
ZNTL D -0.53%
RPTX F -0.46%
REPL D -0.42%
RAPT F -0.4%
AGEN F -0.39%
IMRX F -0.31%
GNLX F -0.24%
Compare ETFs